NCT02311101View on ClinicalTrials.gov

Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Urinary Bladder Neoplasm
Interventions
DRUG

Mitomycin C

Given intravesically

Trial Locations (1)

78229

The University of Texas Health Science Center, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT02311101 - Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer | Biotech Hunter | Biotech Hunter